HHM Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
WA
AFG
GIC
IHL
AP
FMI
CA
FNFDCM
AC
RFA
HHM Wealth Advisors's IBB Position: Q2 2026 in Review
HHM Wealth Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 175 shares worth $33.3K. The position accounts for ﹤0.01% of the portfolio, ranked #447.
HHM Wealth Advisors first reported a position in IBB in Q1 2020 and has held it in 26 quarters since. 320 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- HHM Wealth Advisors held 175 shares of iShares Biotechnology ETF worth $33.3K as of Q2 2026.
- HHM Wealth Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
- iShares Biotechnology ETF made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #447 holding.
- HHM Wealth Advisors first reported a position in iShares Biotechnology ETF in Q1 2020 and has held it in 26 quarters since.
- 320 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.